![]() |
市场调查报告书
商品编码
1744564
2032 年失智症护理产品市场预测:按产品、分销管道、最终用户和地区进行的全球分析Dementia Care Products Market Forecasts to 2032 - Global Analysis By Product (Memory Exercise & Activity Products, Medication Management Products, Daily Reminder Products and Other Products), Distribution Channel, End User and By Geography |
根据 Stratistics MRC 的数据,全球失智症护理产品市场预计在 2025 年达到 2,707 万美元,到 2032 年将达到 4,761 万美元,预测期内的复合年增长率为 8.4%。
失智症护理产品是专门为支持和改善失智症患者生活品质而设计的工具、设备和辅助工具。这些产品旨在提升居家和护理环境中的安全性、独立性、舒适性和认知支持。常见产品包括记忆辅助器、定向手錶、自适应服装、GPS追踪器、感官治疗工具和易于使用的家居用品。这些产品可以减少思维混乱、防止走失、控制焦虑并协助日常生活活动。失智症照护产品也能让照护任务更轻鬆、更有效率,进而为看护者提供支持,最终提升认知衰退患者的整体福祉与尊严。
根据世界卫生组织(WHO)的数据,2023年全球将有约5,500万人罹患失智症,预计2024年将增加至5,700万人。
全球失智症盛行率上升
全球失智症盛行率的上升正推动失智症护理产品市场的快速成长。随着越来越多的个人和家庭面临记忆力衰退和认知能力下降的挑战,对创新有效的解决方案的需求也日益增长,这些解决方案旨在提升他们的生活品质并方便护理。这种激增反过来又推动了辅助器具、安全工具和日常生活辅助设备领域的研究、产品开发和技术进步。因此,市场正呈现积极向上的势头,吸引着投资,并在全球范围内提升了对失智症护理需求的认识。
专业产品高成本
失智症照护专用产品的高昂成本对许多家庭来说是一个重大障碍,限制了他们获得必要的工具和技术。这种经济负担降低了市场需求,并减缓了创新和产品开发。此外,高昂的价格可能会扩大健康差距,因为低收入者难以负担高品质的照护解决方案。结果,市场成长受到阻碍,由于限制了先进专业产品的供应和采用,失智症护理的整体品质可能会下降。
护理产品的技术进步
护理产品的技术进步正在稳步改变失智症护理产品市场,增强患者安全性、提高看护者效率并实现个人化护理。穿戴式健康监测器、GPS 追踪设备和人工智慧认知辅助设备等技术创新有助于早期发现和更好地管理症状。这些技术也减轻了看护者的负担,提高了失智症患者的独立性。因此,对智慧技术整合解决方案的需求正在推动市场成长,并鼓励失智症护理领域的进一步创新。
监管挑战
监管挑战是失智症护理产品市场发展的一大障碍,导致产品认证延迟和开发成本增加。严格的合规要求阻碍了创新,并限制了先进护理解决方案的采用。这些障碍阻碍了投资,减缓了市场成长,并限制了患者获得有效产品的管道。此外,地区间监管差异也使全球分销变得复杂,进一步阻碍了失智症护理关键技术的及时取得和应用。
COVID-19的影响
新冠疫情 (COVID-19) 疫情扰乱了供应链,限制了患者获得基本护理用品,对失智症护理产品市场造成了重大衝击。封锁措施和医疗体系的压力导致面对面援助减少,从而增加了对居家照护解决方案的需求。然而,随着人们对失智症弱势群体的认知度不断提高,远端监控和辅助技术的创新和应用也随之兴起,最终重塑了护理服务模式,并加速了疫情后的市场成长。
认知训练工具市场预计将成为预测期内最大的市场
认知训练工具细分市场提供非侵入式解决方案,以增强认知功能并减缓疾病进展,预计将在预测期内占据最大的市场占有率。这些工具支持记忆力、注意力和解决问题的能力,补充医疗并促进独立生活。它们在家庭和机构中的日益普及反映了人们对非药物干预措施日益增长的认识。随着失智症盛行率的上升,对实证和创新认知训练解决方案的需求正在推动市场成长,并形成一种更全面的失智症护理方法。
预计医院部门在预测期内将以最高复合年增长率成长
由于对先进护理解决方案的需求,预计医院领域将在预测期内实现最高成长率。医院是诊断、治疗和长期照护的关键枢纽,促进了认知辅助设备、监测设备和个人护理工具等创新产品的采用。医院对病人安全、标准化护理和看护者支援的重视,进一步推动了市场成长。此外,基于医院的研究计划和合作正在加速产品开发,提高整体失智症护理的品质和可及性。
由于认知度的提高、老年人口的增长以及医疗基础设施的改善,预计亚太地区将在预测期内占据最大的市场占有率。辅助科技的创新和政府的支持性政策正在增强病患照护和独立性。区域公司加强投资力度以及与全球公司的合作正在提升产品的可用性和定价。这些发展不仅改善了失智症患者的生活质量,也全部区域创造了巨大的经济和就业机会。
在预测期内,由于医疗保健投资的增加,北美地区预计将呈现最高的复合年增长率。辅助科技和居家照护解决方案的进步正在推动需求,从而改善失智症患者的生活品质。政府措施和医疗保健提供者的大力支持进一步推动了市场成长。该地区强大的基础设施和创新生态系统也促进了有效失智症护理产品的开发和应用,有助于市场持续扩张。
According to Stratistics MRC, the Global Dementia Care Products Market is accounted for $27.07 million in 2025 and is expected to reach $47.61 million by 2032 growing at a CAGR of 8.4% during the forecast period. Dementia care products are specialized tools, devices, and aids designed to support individuals living with dementia and improve their quality of life. These products promote safety, independence, comfort, and cognitive support, both at home and in care settings. Common examples include memory aids, orientation clocks, adaptive clothing, GPS trackers, sensory therapy tools, and easy-to-use household items. They help reduce confusion, prevent wandering, manage agitation, and assist with daily living activities. Dementia care products also support caregivers by making care tasks easier and more effective, ultimately enhancing the overall well-being and dignity of those affected by cognitive decline.
According to the World Health Organization, approximately 55 million people worldwide will be living with dementia in 2023, with projections indicating this number will rise to 57 million by 2024.
Rising Global Dementia Prevalence
The rising global prevalence of dementia is driving significant growth in the dementia care products market. As more individuals and families face the challenges of memory loss and cognitive decline, demand increases for innovative, effective solutions that enhance quality of life and ease caregiving. This surge fuels research, product development, and technological advancements in assistive devices, safety tools, and daily living aids. Consequently, the market experiences a positive, forward-driving momentum, attracting investments and fostering global awareness around dementia care needs.
High Costs of Specialized Products
High costs of specialized dementia care products create significant barriers for many families, limiting access to essential tools and technologies. This financial burden reduces market demand, slowing innovation and product development. Additionally, high prices can widen health disparities, as lower-income individuals struggle to afford quality care solutions. Consequently, the market growth is hindered, and overall dementia care quality may decline due to restricted availability and adoption of advanced, specialized products.
Technological Advancements in Care Products
Technological advancements in care products are absolutely transforming the dementia care products market by enhancing patient safety, improving caregiver efficiency, and enabling personalized care. Innovations such as wearable health monitors, GPS tracking devices, and AI-powered cognitive aids support early detection and better management of symptoms. These technologies also reduce caregiver burden and increase independence for individuals with dementia. As a result, demand for smart, tech-integrated solutions is driving market growth and encouraging further innovation in dementia care.
Regulatory Challenges
Regulatory challenges significantly hinder the dementia care products market by causing delays in product approvals and increasing development costs. Strict compliance requirements create barriers for innovation, limiting the introduction of advanced care solutions. These hurdles also discourage investment and slow market growth, restricting access to effective products for patients. Additionally, varying regulations across regions complicate global distribution, further impeding timely availability and adoption of essential dementia care technologies.
Covid-19 Impact
The Covid-19 pandemic significantly impacted the dementia care products market by disrupting supply chains and limiting patient access to essential care items. Lockdowns and healthcare system strains led to reduce in-person support, increasing demand for home-based care solutions. However, heightened awareness of vulnerable populations, like those with dementia, drove innovation and adoption of remote monitoring and assistive technologies, ultimately reshaping care delivery and accelerating market growth post-pandemic.
The cognitive training tools segment is expected to be the largest during the forecast period
The cognitive training tools segment is expected to account for the largest market share during the forecast period as it offers non-invasive solutions that enhance cognitive function and slow disease progression. These tools support memory, attention, and problem-solving skills, complementing medical treatments and promoting independence. Increased adoption in home and institutional settings reflects growing recognition of non-pharmacological interventions. With rising dementia prevalence, the demand for innovative, evidence-based cognitive training solutions is boosting market growth and shaping a more holistic approach to dementia care.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, because of demand for advanced care solutions. Hospitals serve as key centers for diagnosis, treatment, and long-term care, thereby fostering adoption of innovative products such as cognitive aids, monitoring devices, and personal care tools. Their emphasis on patient safety, standardized care, and caregiver support further boosts market growth. Additionally, hospital-based research initiatives and collaborations accelerate product development, enhancing overall dementia care quality and accessibility.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising awareness, growing elderly populations, and improved healthcare infrastructure. Innovations in assistive technologies and supportive government initiatives are enhancing patient care and independence. Increasing investments by regional players and collaborations with global firms are accelerating product availability and affordability. These developments are not only improving quality of life for dementia patients but also creating significant economic and employment opportunities across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increased healthcare investment. Advancements in assistive technologies and home-based care solutions are boosting demand, enabling better quality of life for dementia patients. Government initiatives and strong support from healthcare providers further accelerate market growth. The region's robust infrastructure and innovation ecosystem also foster the development and adoption of effective dementia care products, propelling sustained market expansion.
Key players in the market
Some of the key players profiled in the Dementia Care Products Market include Eli Lilly and Company, Biogen Inc., Johnson & Johnson, Philips Healthcare, GE Healthcare, Medline Industries, Inc., Cardinal Health, Inc., AbbVie Inc., Roche Holding AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Amgen Inc., Pfizer Inc., Lundbeck A/S, GSK plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Beurer GmbH and Doro AB.
In April 2025, GE HealthCare and FPT Corporation have expanded their strategic partnership to accelerate AI-driven healthcare innovation. This collaboration includes the establishment of an FPT Competency Center in Vietnam, aimed at enhancing product strategy, development, and customer onboarding within GE HealthCare's digital ecosystem.
In March 2025, NVIDIA and GE HealthCare have announced a collaboration to advance autonomous diagnostic imaging, focusing on developing AI-driven X-ray and ultrasound technologies. This partnership aims to address the global shortage of radiology professionals and improve access to medical imaging services.
In January 2025, Sutter Health and GE HealthCare have entered into a seven-year strategic partnership, known as the "Care Alliance," aimed at enhancing diagnostic imaging services across California.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.